METHOD OF REDUCING LEVEL OF GLYCEMIA AND INSULIN-RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Russian patent published in 2011 - IPC A61K31/175 A61K31/40 A61K33/24 A61P3/10 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely, to endocrinology, and deals with reduction of glycemia and insulin-resistance level in patients with type 2 diabetes mellitus (DM). For this purpose for 2 months performed is pharmacotherapy, including introduction of januvia in dose 100 mg/day, metformin in dose 2000 mg/day, chromium picolinate in dose 1000 mcg/day. From the third day of pharmacotherapy administered is complex of physical exercises in form of dosed walking on treadmill in mode of step-load: first day - rate 3 km/hour, load duration - 2 min, second day - rate 4.6 km/hour, load duration - 1 min, third day: rate 4.8 km/hour, load duration - 2 min, fourth day: rate 5 km/hour, duration - 3 min, fifth day - rate 5.2 km/hour, duration - 4 minutes. After that, intensity of load is reduced in reverse order, with total duration of dosed load to 15 min and distance length - to 1220 m.

EFFECT: complex treatment ensures efficient reduction of glycemia level in patients with type 2 DM in stage of decompensation without application of insulin therapy.

3 ex